International evidence increasingly shows that puberty blockers and cross-sex hormones carry significant physical and psychological risks, including loss of bone density, infertility, and long-term regret. Countries such as the United Kingdom, Finland, and Sweden have now restricted their use in children after concluding that the evidence for safety and effectiveness is weak. Australia should follow suit and place a moratorium on the medical transition of minors until robust, long-term research can demonstrate any clear benefits and safeguards.

Australia urgently needs a transparent, nationwide review similar to the UK’s Cass Review. This inquiry should examine clinical practices, referral patterns, and the evidence base underpinning gender treatments for minors. It should also assess the role of ideology in shaping medical policy and ensure that healthcare professionals are free to provide evidence-based care without pressure to “affirm” a child’s chosen gender identity. An independent inquiry would help restore public trust and ensure children receive care that prioritises their long-term wellbeing.

Research consistently shows that most children experiencing gender distress also face other challenges such as anxiety, depression, trauma, or autism spectrum conditions. Instead of rushing toward medical interventions, Australia’s approach must emphasise comprehensive psychological assessment and family involvement. Providing time, therapy, and relational support allows many young people to find peace with their biological sex — addressing underlying distress rather than masking it with irreversible treatments.